Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe history now shows a new latest revision labeled v3.5.5, with the previous v3.5.4 removed from the record. This update changes the page's revision metadata rather than the study content or results.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedVersion 53 (v3.5.4) was released on 2026-05-13. It adds Contacts/Locations and Study Status sections to the study record history.SummaryDifference0.3%

- Check50 days agoChange DetectedThe page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, reflecting a backend or platform update rather than a change to the clinical trial record information.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded Record History and Study Record Versions with version-by-version details and a compare option, plus related UI elements (Results Posted, Researcher View, Study Details, Download, Save) to improve traceability of the trial record.SummaryDifference39%

- Check93 days agoChange DetectedRevision: v3.4.3 added; several history-related sections appear removed or hidden, with updated UI for versioning.SummaryDifference14%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.